Home
Live Updates
Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema : comparemela.com
Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema
Donidalorsen delivered significant and sustained reductions in HAE attacks, with high levels of disease control and improvement in quality of life measures with monthly or every two-month dosing;...
Related Keywords
Spain ,
California ,
United States ,
San Diego ,
Valencia ,
Carabobo ,
Venezuela ,
Kenneth Newman ,
D Wade Walke ,
Hayley Soffer ,
Marc Riedl ,
European Academy Of Allergy ,
Linkedin ,
Exchange Commission ,
Angioedema Center ,
European Medicines Agency ,
Division Of Allergy Immunology ,
Otsuka Pharmaceutical Co Ltd ,
Drug Administration ,
Prnewswire Ionis Pharmaceuticals Inc ,
Nasdaq ,
University Of California ,
Ionis Pharmaceuticals ,
Ionis Pharmaceuticals Inc ,
European Academy ,
Clinical Immunology ,
Annual Congress ,
Brett Monia ,
Study Results ,
Open Label Extension ,
New Drug Application ,
Marketing Authorization Application ,
Hereditary Angioedema ,
Conjugated Antisense ,
Investor Contact ,
Wade Walke ,
Media Contact ,
Allergy Organ ,
comparemela.com © 2020. All Rights Reserved.